Your session is about to expire
← Back to Search
Growth Hormone + Liraglutide for Metabolic Health Improvement
Study Summary
This trial will test the effects of Growth Hormone & Liraglutide on adults to measure insulin resistance, energy expenditure & body composition.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have other pituitary, liver, or kidney diseases.I have a history of cancer, diabetes, thyroid issues, or pancreatitis.I haven't taken steroids, hormones, or weight loss drugs in the last 6 months.I have growth hormone deficiency and need medication for diabetes.I am overweight or mildly obese with a high waist circumference.I am overweight with a BMI between 25-34.9 and have a waist size of at least 102 cm if male, or 88 cm if female.I am overweight/obese with no other medical conditions.I have been diagnosed with growth hormone deficiency in the last year.I am lean with a BMI between 19 and 24.9 and do not meet the waist circumference criteria.I haven't taken growth hormone therapy in the last year.I am not taking any prescription medications or drugs.My thyroid, adrenal, and reproductive glands are functioning normally.I am one of 24 patients with a specific growth hormone deficiency.I have a history of cancer, pancreatitis, or thyroid cancer.I am a healthy individual, aged 18-45.I have been diagnosed with isolated growth hormone deficiency.I am between 18 and 45 years old.I am healthy, aged 18-45, and fit the gender requirement.I am lean with a BMI between 19 and 24.9 and do not meet the waist circumference criteria.
- Group 1: Growth hormone and liraglutide
- Group 2: Growth hormone
- Group 3: Liraglutide
- Group 4: Placebo
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the FDA sanction Growth hormone for medicinal usage?
"Growth hormone has been approved, thus its safety rating is a 3."
Is this investigation recruiting participants at the moment?
"According to information found on clinicaltrials.gov, this experiment is no longer recruiting patients as of December 27th 2022. Although the trial has ended, 804 other research projects are still seeking participants presently."
Does the research protocol for this investigation permit individuals aged 45 or above to participate?
"This clinical trial is limited to 18-45 year old participants. However, there are additional trials available for both those under the age of majority as well as seniors aged 65 and up with 60 studies dedicated solely to minors and 350 specifically designed for elderly patients."
Are there any eligibility requirements to join this experiment?
"This trial seeks to enrol 40 adults with growth hormone deficiency ranging between 18 and 45 years old. Of these, 20 must be overweight or obese (as classified by body mass index) with a waist circumference greater than 102cm in men and 88 cm in women (except East/South Asians whose criteria differs). The other half of participants should be leaner individuals not meeting the WC requirements. Additionally, all potential patients need to have normal blood pressure levels, hemoglobin A1C concentration below 5.7%, fasting plasma glucose concentrations under 100mg/dL, regular thyroid-stimulating hormone readings, nonhormonal contraceptive methods for premenopausal"
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger